当前位置：首页 > 文献互助 > 互助详情

ANGPTL3-lowering strategies to address residual cardiovascular risk复制

用户wxb8loTerxGI 5天前 33 10 已完结

1. 当前求助状态已完结, 请及时下载应助文件

2. 系统将在 2026-04-23 17:24:16 删除文件

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

F Mohamed, FJ Raal
Nature Reviews Cardiology, 2026
nature.com
Angiopoietin-related protein 3 (ANGPTL3)-lowering therapies are an LDL receptor-independent strategy for patients who remain at high cardiovascular risk despite conventional treatment, including those with familial hypercholesterolaemia. By reducing both LDL-cholesterol and triglyceride-rich lipoprotein levels in plasma, ANGPTL3 inhibition addresses a broader atherogenic burden and might offer advantages over apolipoprotein C3 inhibition, with the potential to reshape the management of refractory dyslipidaemias …

上一篇：The Multifaceted Role of Angiopoietin-Like Proteins in Coronary Heart Disease: From Molecular Mechanisms to Clinical Translation

下一篇：The evaluation of plozasiran for the treatment of familial chylomicronemia syndrome

互助时间线

2026-04-17 08:39:20 [完结求助]

楼主确认了jodie0105应助的文件是正确的, 求助状态变成 已完结

2026-04-16 17:24:16 [上传文件]

jodie0105上传了文件(pdf 806.48 KB), 求助状态变成 待确认

2026-04-16 17:17:34 [发起求助]

最新发布的求助

Protein-templated synthesis of dinucleotide repeat DNA by an antiphage reverse transcriptase 7分钟前
Efficacy and safety of inclisiran in adolescents with heterozygous familial hypercholesterolaemia (ORION-16): a two-part, randomised, multicentre clinical trial 8分钟前
Postoperative recovery with remimazolam versus propofol in elderly patients undergoing daytime ocular fundus surgery under general anesthesia: a multicenter randomized non-inferiority trial 29分钟前
Quantitation of thiorphan in human plasma using LC-MS/MS and its application to a bioequivalence study 37分钟前
Zongertinib in Previously Treated HER2 -Mutant Non–Small-Cell Lung Cancer 43分钟前
Advancing Seawater Electrolysis: NiFe‐LDH‐Based Electrocatalysts for the Oxygen Evolution Reaction 1小时前
Aumolertinib as adjuvant therapy in resected EGFR-mutated non-small-cell lung cancer (ARTS): a double-blind, multicentre, randomised, controlled, phase 3 trial 1小时前
Over-testing for suspected pulmonary embolism in American emergency departments: the continuing epidemic 1小时前
Savolitinib plus osimertinib versus chemotherapy for advanced, EGFR mutation-positive, MET-amplified non-small-cell lung cancer in China (SACHI): interim analysis of a multicentre, open-label, phase 3 randomised controlled trial 1小时前
CLO26-102: Progression-Free Survival of Pembrolizumab Monotherapy Versus Combination Therapy With Chemotherapy as First-Line Treatment in Advanced or Metastatic Non-Small-Cell Lung Cancer Without EGFR/ALK Mutations 1小时前
YNbO4:RE3+ (RE = Eu, Sm, Pr, Dy) phosphors: The luminescence properties and The energy transfer between the host and the RE3+ ions 1小时前
Doubling the relative sensitivity of YNbO4:Sm3+ luminescence thermometer by observing 4G7/2 emitting level 1小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com